Hydrogen peroxide generation by polymorphonuclear leukocytes exposed to peritoneal dialysis effluent. 1996

I Daniels, and K S Bhatia, and C J Porter, and M A Lindsay, and A G Morgan, and R P Burden, and J Fletcher
Medical Research Centre, City Hospital, Nottingham, United Kingdom.

In the presence of peritoneal dialysis effluent (PDE), human polymorphonuclear leukocytes (PMN) showed reduced production of hydrogen peroxide and hypochlorous acid (H2O2 and HOCl, respectively) when at rest and when stimulated with both soluble (formylmethionyl-leucyl-phenylalanine and phorbol myristate acetate) and particulate (Staphylococcus epidermidis) agonists. This effect occurred in a concentration-dependent manner between 0 and 70%. (vol/vol) dialysis effluent. The inhibition of H2O2 and HOCl observed in resting, formy-methionylleucyphenyalanine-stimulated, and S. epidermidis-stimulated PMN was confined to a low-molecular-mass (< 10,000-Da) fraction of PDE, whereas the inhibition of the PMA response was equally dispersed throughout both low (< 10,000-Da)- and high-molecular-mass (> 10,000-Da) fractions. Human serum albumin, a major component of PDE, also inhibited H2O2 and HOCl production by PMN; however, results from cell-free systems suggested that human serum albumin was not wholly responsible for the inhibition of PMN function seen with PDE. The solute(s) responsible did not affect myloperoxidase but very rapidly scavenged H2O2 and HOCl. These data suggest that the factors capable of affecting H2O2 and HOCl production by PMN accumulate in uremia and are removed from the circulation into dialysis effluent.

UI MeSH Term Description Entries
D006997 Hypochlorous Acid An oxyacid of chlorine (HClO) containing monovalent chlorine that acts as an oxidizing or reducing agent. Hypochlorite,Hypochlorous Acids
D009504 Neutrophils Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes. LE Cells,Leukocytes, Polymorphonuclear,Polymorphonuclear Leukocytes,Polymorphonuclear Neutrophils,Neutrophil Band Cells,Band Cell, Neutrophil,Cell, LE,LE Cell,Leukocyte, Polymorphonuclear,Neutrophil,Neutrophil Band Cell,Neutrophil, Polymorphonuclear,Polymorphonuclear Leukocyte,Polymorphonuclear Neutrophil
D010530 Peritoneal Dialysis Dialysis fluid being introduced into and removed from the peritoneal cavity as either a continuous or an intermittent procedure. Dialyses, Peritoneal,Dialysis, Peritoneal,Peritoneal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006861 Hydrogen Peroxide A strong oxidizing agent used in aqueous solution as a ripening agent, bleach, and topical anti-infective. It is relatively unstable and solutions deteriorate over time unless stabilized by the addition of acetanilide or similar organic materials. Hydrogen Peroxide (H2O2),Hydroperoxide,Oxydol,Perhydrol,Superoxol,Peroxide, Hydrogen
D001202 Ascitic Fluid The serous fluid of ASCITES, the accumulation of fluids in the PERITONEAL CAVITY. Peritoneal Effusion,Peritoneal Fluid,Ascitic Fluids,Effusion, Peritoneal,Fluid, Ascitic,Fluid, Peritoneal,Peritoneal Effusions,Peritoneal Fluids
D015314 Dialysis Solutions Solutions prepared for exchange across a semipermeable membrane of solutes below a molecular size determined by the cutoff threshold of the membrane material. Dialysate,Dialysis Solution,Dialyzate,Dialysates,Dialyzates,Solution, Dialysis,Solutions, Dialysis

Related Publications

I Daniels, and K S Bhatia, and C J Porter, and M A Lindsay, and A G Morgan, and R P Burden, and J Fletcher
March 1994, Clinical and diagnostic laboratory immunology,
I Daniels, and K S Bhatia, and C J Porter, and M A Lindsay, and A G Morgan, and R P Burden, and J Fletcher
August 1994, Clinical and diagnostic virology,
I Daniels, and K S Bhatia, and C J Porter, and M A Lindsay, and A G Morgan, and R P Burden, and J Fletcher
August 1994, Acta paediatrica Japonica : Overseas edition,
I Daniels, and K S Bhatia, and C J Porter, and M A Lindsay, and A G Morgan, and R P Burden, and J Fletcher
January 1993, Nephron,
I Daniels, and K S Bhatia, and C J Porter, and M A Lindsay, and A G Morgan, and R P Burden, and J Fletcher
March 1977, Blood,
I Daniels, and K S Bhatia, and C J Porter, and M A Lindsay, and A G Morgan, and R P Burden, and J Fletcher
February 1998, Diabetes care,
I Daniels, and K S Bhatia, and C J Porter, and M A Lindsay, and A G Morgan, and R P Burden, and J Fletcher
December 1979, Experimental cell research,
I Daniels, and K S Bhatia, and C J Porter, and M A Lindsay, and A G Morgan, and R P Burden, and J Fletcher
September 1998, Clinical and diagnostic laboratory immunology,
I Daniels, and K S Bhatia, and C J Porter, and M A Lindsay, and A G Morgan, and R P Burden, and J Fletcher
January 1997, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis,
I Daniels, and K S Bhatia, and C J Porter, and M A Lindsay, and A G Morgan, and R P Burden, and J Fletcher
January 1982, Advances in experimental medicine and biology,
Copied contents to your clipboard!